IGMIN: We're glad you're here. Please click 'create a new query' if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click 'take me to my Query.'
Welcome to IgMin Research – an Open Access journal uniting Biology, Medicine, and Engineering. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.
Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.
IgMin Publications Inc., Suite 102, West Hartford, CT - 06110, USA
We aim to facilitate the cross-pollination of ideas across disciplines to boost scientific progress.
Biography
Biography of Jeffrey Jones
Dr. Jeffrey Jones is an academic researcher affiliated with the University of Zagreb in Croatia, where he contributes to interdisciplinary studies within the fields of biological and environmental sciences. With a diverse research background, Dr. Jones is known for his analytical approach to complex scientific challenges and a commitment to international collaboration. His recent work, published under IgMin Research, reflects a strong interest in sustainability, emerging biotechnologies, and their applications in ecological conservation and public health.
Dr. Jones’s academic journey combines extensive cross-border experience with a deep-rooted passion for innovation and education. At the University of Zagreb, he is actively involved in both teaching and research, engaging with students and peers to foster a forward-thinking, research-intensive environment. His work is characterized by a methodological rigor that bridges theoretical frameworks with applied scientific inquiry.
Through contributions to academic journals, conferences, and collaborative projects, Dr. Jones has established himself as a thoughtful voice in discussions around global scientific development. He remains particularly interested in advancing research that supports evidence-based policymaking and the integration of technology in environmental monitoring.
While based in Croatia, Dr. Jones maintains active connections with the international academic community, and regularly collaborates with researchers across Europe and beyond. His open, interdisciplinary perspective and dedication to research excellence continue to shape his role as an influential contributor to contemporary scientific discourse.
Research Interest
Dr. Jeffrey Jones’s research interests center on the intersection of environmental science, biotechnology, and sustainability. He is particularly focused on microbial ecology, environmental monitoring, and the application of biotechnology to address ecological and public health challenges. His work often explores how microbial systems can be leveraged for bioremediation, pollution control, and sustainable agriculture.
In addition, Dr. Jones is interested in interdisciplinary research that integrates data science and remote sensing technologies to enhance environmental analysis and decision-making. He is committed to advancing sustainable solutions that bridge scientific research with practical applications in resource management, climate adaptation, and biodiversity conservation.
As a researcher at the University of Zagreb, Dr. Jones actively collaborates with colleagues across Europe, contributing to projects that align with the UN Sustainable Development Goals (SDGs). His current studies aim to improve understanding of environmental processes through both laboratory-based and field-oriented approaches.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
Avian macrorhabdosis is a disease of wild and captive birds (psittacines, passerines and other species) distributed worldwide, and is caused by the opportunistic yeast Macrorhabdus ornithogaster. The disease is usually chronic, and is manifested by nonspecific clinical signs (emaciation, anorexia, depression, cachexia and ultimately death), or gastrointestinal signs (regurgitation or attempted vomiting, watery diarrhea, and weight loss despite preserved appetite). It can also occur in a subclinical form, while the clinical disease can last for ...weeks, months (or even years). Diagnosis and therapy are still challenging for bird specialists for many reasons. During life, the diagnosis is made directly from stool smears after Gram staining by finding characteristic large, Gram-positive, 20 μm - 80 μm long and 3 μm - 4 μm wide rods, as well as a smear of the isthmus (proventricular-ventricular junction) after dissection. Early detection is possible using newly developed PCR tests. The only available drug against avian macrorhabdosis is amphotericin B, which is not effective in many cases regardless of the dose and duration of therapy. Although many birds have the causative agent in their digestive system, the disease is most likely to occur as a result of weakened immunity due to stress, poor hygiene, improper housing conditions and improper feeding, so regular periodic testing for macrorhabdosis is necessary.
0000-0002-7229-9596 
